Support PenkeBioatla Inc - Trending symbols
Latest News of Bioatla Inc
| Date | Title | Read |
|---|---|---|
| 2025-11-21 06:25 | BioAtla Enters into Agreements for up to $22.5 Million Flexible Financing | Read |
| 2025-10-23 14:00 | BioAtla Presents Compelling Mechanistic Rationale for Targeting ROR2 with Ozuriftamab Vedotin (Oz-V) in Oropharyngeal Squamous Cell Carcinoma (OPSCC) at the Annual Conference of the International Papillomavirus Society | Read |
Notifications
| Type | Notification | Date |
|---|---|---|
| RSI Overbought | Overbought RSI (Relative Strength Index) | 2025-11-19 |
Trends
| 2024-06-30 | 2024-09-30 | 2024-12-31 | 2025-03-31 | 2025-06-30 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Total Other Income Expense Net | 900 | -216 | 684 | 676 | 1,360 | 920 | 2,280 | -2,344 | -64 | |
| Total Stockholder Equity | 31,370 | -8,402 | 22,968 | -8,703 | 14,265 | -13,718 | 547 | -17,292 | -16,745 | |
| Net Invested Capital | 31,370 | -8,402 | 22,968 | -8,703 | 14,265 | -13,718 | 547 | -17,292 | -16,745 | |
| Interest Expense | 949 | 681 | 1,630 | -241 | 1,389 | -1,386 | 3 | -1,661 | -1,658 | |
| Income Tax Expense | 204 | 1,343 | 1,547 | -159 | 1,388 | -1,384 | 4 | -1,203 | -1,199 | |
| Reconciled Depreciation | 314 | -1 | 313 | -25 | 288 | 12 | 300 | -600 | -300 |
Comments
How you think about this?